---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-008884"
form_type: "8-K"
ticker: "PHIO"
cik: "0001533040"
company_name: "Phio Pharmaceuticals Corp."
filed_at: "2024-12-20T23:59:59+00:00"
generated_at: "2026-05-29T00:16:26.243639+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Phio Pharma raises ~$1.15M in registered direct offering & private placement

## Summary
- Gross proceeds ~$1.15M; net proceeds ~$900K after fees and expenses.
- Sold 437,192 shares at $2.635/share in registered direct offering.
- Concurrent private placement: warrants to purchase 437,192 shares at $2.51, 5-year term.
- Proceeds to be used for working capital and general corporate purposes.
- H.C. Wainwright acted as placement agent receiving 7.5% fee plus warrants.

## SEC filing metadata
- accession: 0001683168-24-008884
- form_type: 8-K
- ticker: PHIO
- cik: 0001533040
- company_name: Phio Pharmaceuticals Corp.
- filed_at: 2024-12-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533040/000168316824008884/0001683168-24-008884-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533040/000168316824008884/phio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-008884
- JSON: https://secwatch.observer/filing/0001683168-24-008884.json
- Plain text: https://secwatch.observer/filing/0001683168-24-008884.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.